DROR ORTHO-DESIGN INC (DROR) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 16, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the S-1/A for Q2 FY2026, filed Sep 16, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DROR SEC filings page.
This page shows DROR ORTHO-DESIGN INC (DROR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The balance sheet reversed from equity-funded to liability-heavy by FY2025, while reported cash-flow evidence remains incomplete.
Equity moved from$3.2M in FY2023 to-$2.9M in FY2025, while liabilities rose sharply. By FY2025, the current ratio was 0.1 versus 11.7 in FY2023, indicating obligations had become far less covered by near-term assets.
In FY2024, operating cash flow was
FY2023 paired operating cash flow of
Financial Health Signals
DROR ORTHO-DESIGN INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
DROR ORTHO-DESIGN INC's EBITDA was -$494K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
DROR ORTHO-DESIGN INC reported a net loss of $625K in Q2 2026. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
DROR ORTHO-DESIGN INC earned $0.00 per diluted share (EPS) in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Not reported for Q2 2026.
Cash & Balance Sheet
DROR ORTHO-DESIGN INC held $94K in cash as of Q2 2026; no long-term debt figure is on record for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
None of these metrics is reported for Q2 2026.
Capital Allocation
DROR ORTHO-DESIGN INC invested $151K in research and development in Q2 2026. This represents a decrease of 53.5% from the same quarter a year earlier. Against the prior quarter it is up 27.3%.
Not reported for Q2 2026.
Not reported for Q2 2026.
DROR Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'26S-1/A | Q1'26S-1/A | Q4'25S-1/A | Q3'2510-Q | Q2'25S-1/A | Q1'25S-1/A | Q4'24S-1/A | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| R&D Expenses | $151K-53.5% | $118K-50.6% | $816K-47.0% | $151K-66.4% | $324K-16.7% | $240K-35.9% | $1.5M | $451K+38.6% |
| SG&A Expenses | $345K-11.9% | $379K+20.8% | N/A | $318K+3.5% | $391K+17.5% | $314K-18.7% | $1.4M | $308K+35.2% |
| Operating Income | -$496K | -$497Kn/m | N/A | -$470Kn/m | N/A | -$576Kn/m | N/A | -$1.3Mn/m |
| EBITDA | -$494K | -$496Kn/m | N/A | -$469Kn/m | N/A | -$575Kn/m | N/A | -$1.3Mn/m |
| Net Income | -$625K | -$639Kn/m | N/A | -$654Kn/m | N/A | -$576Kn/m | N/A | -$1.8Mn/m |
| EPS (Basic) | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00 | $0.00 | -$0.01 | $0.00 |
| EPS (Diluted) | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00 | $0.00 | -$0.01 | $0.00 |
| Diluted Shares (Avg) | 977M+2.1% | 976M+2.0% | 957M+42.3% | 957M+29.6% | 957M | 957M | 673M | 738M |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, Interest Expense, Income Tax.
DROR Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'26S-1/A | Q1'26S-1/A | Q4'25S-1/A | Q3'2510-Q | Q2'25S-1/A | Q1'25S-1/A | Q4'24S-1/A | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $366K+175.8% | $254K-42.8% | $259K-60.9% | $271K-78.6% | $133K-93.1% | $443K-83.4% | $663K-80.9% | $1.3M-69.6% |
| Current Assets | $348K+213.9% | $235K-44.1% | $239K-62.6% | $251K-79.8% | $111K-94.1% | $420K-84.2% | $639K-81.6% | $1.2M-70.2% |
| Cash & Equivalents | $94K+45.1% | $24K-93.2% | $229K-58.4% | $240K-79.0% | $64K-96.5% | $350K-86.3% | $549K-83.6% | $1.1M-71.5% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Total Liabilities | $4.3M+139.5% | $3.6M+161.4% | $3.1M+203.9% | $2.6M+189.9% | $1.8M+583.3% | $1.4M+381.5% | $1.0M+240.9% | $893K-9.0% |
| Current Liabilities | $4.1M+150.1% | $3.4M+174.6% | $3.0M+226.1% | $2.4M+172.6% | $1.6M+535.5% | $1.2M+342.4% | $907K+205.2% | $888K-9.5% |
| Non-Current Liabilities | $203K+28.8% | $187K+39.8% | $176K+42.0% | $169K+3188.2% | $158K+3016.4% | $134K+2485.6% | $124K+2264.7% | $5K+1238.4% |
| Total Equity | -$3.9Mn/m | -$3.3Mn/m | -$2.9Mn/m | -$2.3M-719.0% | -$1.7M-200.4% | -$921K-138.5% | -$368K-111.6% | $374K-88.2% |
| Retained Earnings | -$23.3Mn/m | -$22.7Mn/m | -$22.1Mn/m | -$21.5Mn/m | -$20.8Mn/m | -$20.8Mn/m | -$19.5Mn/m | -$18.4Mn/m |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
DROR Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'26S-1/A | Q1'26S-1/A | Q4'25S-1/A | Q3'2510-Q | Q2'25S-1/A | Q1'25S-1/A | Q4'24S-1/A | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$305Kn/m | -$404Kn/m | -$649Kn/m | -$424Kn/m | -$485Kn/m | -$500Kn/m | -$563Kn/m | -$691Kn/m |
| Depreciation & Amortization | $1K+8.2% | $1K+6.4% | $1K+0.5% | $1K+1.6% | $1K+10.6% | $1K+165.0% | $1K+635.1% | $1K+639.5% |
| Stock-Based Compensation | N/A | N/A | $39K-98.3% | N/A | $16K-97.9% | $23K-95.7% | $2.2M | $543K+21485.9% |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | $0 | $0 |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | -$563K | -$691K |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | $0n/m | $0 |
| Financing Cash Flow | $375K+87.5% | $200K-33.3% | $650K | $600K | $200K | $300K | N/A | N/A |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
DROR Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'26S-1/A | Q1'26S-1/A | Q4'25S-1/A | Q3'2510-Q | Q2'25S-1/A | Q1'25S-1/A | Q4'24S-1/A | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -487.9%-470.5pp |
| Return on Assets | -170.9% | -251.7%-121.7pp | N/A | -241.0%-96.8pp | N/A | -130.0%-81.0pp | N/A | -144.1%-130.8pp |
| Current Ratio | 0.080.0x | 0.07-0.3x | 0.08-0.6x | 0.10-1.3x | 0.07-7.3x | 0.34-9.2x | 0.70-10.9x | 1.40-2.8x |
| Liabilities-to-Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2.38+2.1x |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Debt-to-Equity, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$2.9M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.08), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Where DROR ORTHO-DESIGN INC Ranks
Frequently Asked Questions
What are DROR ORTHO-DESIGN INC's total assets?
DROR ORTHO-DESIGN INC (DROR) had $259K in total assets as of fiscal year 2025, including both current and long-term assets.
What are DROR ORTHO-DESIGN INC's capital expenditures?
DROR ORTHO-DESIGN INC (DROR) invested $966 in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does DROR ORTHO-DESIGN INC spend on research and development?
DROR ORTHO-DESIGN INC (DROR) invested $816K in research and development during fiscal year 2025.
What is DROR ORTHO-DESIGN INC's current ratio?
DROR ORTHO-DESIGN INC (DROR) had a current ratio of 0.08 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is DROR ORTHO-DESIGN INC's P/E ratio?
DROR ORTHO-DESIGN INC (DROR) has no price-to-earnings ratio at the moment: no net income reported. The market capitalization is $8.3M as of Oct 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is DROR ORTHO-DESIGN INC's price-to-sales ratio?
DROR ORTHO-DESIGN INC (DROR) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $8.3M as of Oct 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Why is DROR ORTHO-DESIGN INC's debt-to-equity ratio negative or not reported?
DROR ORTHO-DESIGN INC (DROR) has negative shareholder equity of -$2.9M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.